Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-23-005232

CHIEF OPERATING OFFICER gave up 1,453 shares (to pay taxes)

  • CHIEF OPERATING OFFICER acquired 4,946 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tessari Eben CHIEF OPERATING OFFICER 2023-03-16 Option exercise +1,964 116,612 D
Tessari Eben CHIEF OPERATING OFFICER 2023-03-16 Shares withheld for taxes −577 $11.46 $6,612 116,035 D
Tessari Eben CHIEF OPERATING OFFICER 2023-03-20 Option exercise +2,982 119,017 D
Tessari Eben CHIEF OPERATING OFFICER 2023-03-20 Shares withheld for taxes −876 $11.12 $9,741 118,141 D
Derivatives
Tessari Eben CHIEF OPERATING OFFICER 2023-03-16 Option exercise · Restricted Share Unit −1,964 3,928 D
Tessari Eben CHIEF OPERATING OFFICER 2023-03-20 Option exercise · Restricted Share Unit −2,982 0 D
Loading xslF345X04/form4-03202023_090331.xml…